Cargando…
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
Over the last two decades, many studies have demonstrated that the insulin-like growth factor-1 (IGF-1) is involved in a number of patho-physiological processes, as well as in the development of different types of solid tumors, including breast cancer (BC). Preclinical and clinical data showed that...
Autores principales: | Ianza, Anna, Sirico, Marianna, Bernocchi, Ottavia, Generali, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019779/ https://www.ncbi.nlm.nih.gov/pubmed/33829018 http://dx.doi.org/10.3389/fcell.2021.641449 |
Ejemplares similares
-
The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review
por: Ruocco, Anna, et al.
Publicado: (2022) -
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022) -
A Balanced Act: The Effects of GH–GHR–IGF1 Axis on Mitochondrial Function
por: Hu, Bowen, et al.
Publicado: (2021) -
Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023) -
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
por: Schettini, Francesco, et al.
Publicado: (2020)